CD274 and neoplasm: A correct standardization of IHC protocols for the detection of PD-L1 in tumor cells in different cancer subtypes and a definition of an adequate cut-off in terms of percentage of positive cells will enable reevaluating the prognostic value of this marker, but especially highlighting its predictive value for the therapeutic stratification of cancer patients.